Cargando…
SNP rs2240688 in CD133 gene on susceptibility and clinicopathological features of hepatocellular carcinoma
BACKGROUND: CD133 is one of the important cancer stem cells (CSCs) markers of hepatocellular carcinoma (HCC). The aim of this study was to explore the relationship between CD133 single-nucleotide polymorphisms (SNPs) and risk factors associated with HCC susceptibility and clinicopathological feature...
Autores principales: | Pan, Xiaolan, Huang, Lingsha, Mo, Dan, Liang, Yihua, Huang, Zhaodong, Zhu, Bo, Fang, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799249/ https://www.ncbi.nlm.nih.gov/pubmed/35117206 http://dx.doi.org/10.21037/tcr-19-2690 |
Ejemplares similares
-
Gene Combination of CD44 rs187116, CD133 rs2240688, NF-κB1 rs28362491 and GSTM1 Deletion as a Potential Biomarker in Risk Prediction of Breast Cancer in Lower Northern Thailand
por: Sapcharoen, Kamonpat, et al.
Publicado: (2019) -
CD44, IL-33, and ST2 Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility in the Chinese Population
por: Pan, Xiaolan, et al.
Publicado: (2020) -
The Association between PON1 (Q192R and L55M) Gene Polymorphisms and Risk of Cancer: A Meta-Analysis Based on 43 Studies
por: Pan, Xiaolan, et al.
Publicado: (2019) -
CD133 expression correlates with clinicopathologic features and poor prognosis of colorectal cancer patients: An updated meta-analysis of 37 studies
por: Huang, Rongyong, et al.
Publicado: (2018) -
CD44 Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathologic Features
por: Chou, Ying-Erh, et al.
Publicado: (2014)